본문

서브메뉴

Biomanufacturing of Kidney Organoids, Perfusable Proximal Tubules, and Kidney Tissues
Biomanufacturing of Kidney Organoids, Perfusable Proximal Tubules, and Kidney Tissues
Biomanufacturing of Kidney Organoids, Perfusable Proximal Tubules, and Kidney Tissues

상세정보

자료유형  
 학위논문 서양
최종처리일시  
20260202103552
ISBN  
9798280715462
DDC  
610
저자명  
Aceves, Jeffrey Ooi.
서명/저자  
Biomanufacturing of Kidney Organoids, Perfusable Proximal Tubules, and Kidney Tissues
발행사항  
[Sl] : Harvard University, 2025
발행사항  
Ann Arbor : ProQuest Dissertations & Theses, 2025
형태사항  
145 p
주기사항  
Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
주기사항  
Advisor: Lewis, Jennifer A.
학위논문주기  
Thesis (Ph.D.)--Harvard University, 2025.
초록/해제  
요약Human kidneys are vital organs that filter blood, regulate electrolyte homeostasis, and produce urine. These complex processes are carried out by nephron subunits composed of glomeruli and tubular segments that are responsible for filtration and reabsorption, respectively. While considerable efforts have focused on the fabrication of in vitro renal models that recapitulate nephron structure and function for studying nephrotoxicity and renal development, progress remains limited. Kidney organoids derived from human induced pluripotent stem cells (hiPSCs) are three dimensional (3D), multicellular structures that contain many of the cell types and architectures present in human kidneys. There is a growing interest in using kidney organoids as a platform for improved drug screening and as organ building blocks (OBBs) for the biomanufacturing of functional kidney tissues for modeling tissue development, and ultimately, renal replacement.The overarching goal of this Ph.D. thesis is to generate kidney organoids and explore their use as building blocks for biofabricating perfusable proximal tubules, and bulk kidney tissues. Specifically, this research focuses on the scalable 3D differentiation of kidney organoids in stirred bioreactors (STRs), the development of organoid-derived perfusable proximal tubules-on-chip, and the biofabrication of 3D kidney tissues for in vitro and in vivo assessment. We first investigated the effect of hiPSC seeding density and stir rate on embryoid body (EB) formation and differentiation efficiency. Their initial differentiation efficiency was roughly 70%, which motivated the development of an optical-based screening method to rapidly predict differentiation success. Next, the concentration and timing of differentiation reagents along with improved media preparation methods were implemented to further enhance the differentiation efficiency of nephron-rich kidney organoids to roughly 95%. The STR-generated kidney organoids exhibited glomerular, proximal tubule, distal tubule, stromal and vascular cell types and architectures. Compared to kidney organoids differentiated in static conditions, STR-generated kidney organoids demonstrated increased expression of tubular, ciliary, and vascular cell types. Most importantly, kidney organoid differentiation in stirred bioreactors greatly increased the organoid volume produced in a given time period relative to 2D (static) differentiation methods.Next, we developed an organoid-derived proximal tubule epithelial cell (OPTEC)-on-chip model that exhibits improved drug uptake compared to those based on tert1-immortalized proximal tubule (PTEC-TERT) cells. First, lotus tetragonolobus lectin (LTL+) proximal tubule cells are isolated from mature kidney organoids, that were dissociated into individual cells, using magnetic activated cell sorting (MACS) and expanded in vitro. These OPTECs are then seeded into cylindrical channels embedded within an optimized extracellular matrix (ECM) composed of gelatin-fibrin, where they form a confluent monolayer. A second bare channel is introduced adjacent to this 3D tubule within reusable multiplexed chips to mimic basolateral drug uptake. Our 3D OPTEC-on-chip model exhibits significant upregulation and improved polarization of organic cation 2 (OCT2) and organic anion 1/3 (OAT1/3) transporters, which resulted in higher drug uptake compared to PTEC-TERT-on-chip controls. Consequently, OPTEC-on-chip models also exhibited a higher normalized lactate dehydrogenase (LDH) release compared to those controls when exposed to known nephrotoxins, cisplatin and aristolochic acid. Importantly, LDH release could be diminished by adding known OCT2 and OAT1/3 inhibitors. This integrated multifluidic OPTEC platform paves the way for personalized kidney-on-chip models for drug screening and disease modeling.Finally, we investigated the biofabrication of 3D kidney tissues from OBBs with the goal of modeling in vitro tissue development and assessing their host integration in vivo. Kidney organoids differentiated from hiPSCs in STRs were mixed in a fibrinogen solution and compacted to form a cellularly dense tissue matrix. Sacrificial writing into functional tissue (SWIFT) is then used to print sacrificial ink channels into the OBB-ECM matrix. The SWIFT kidney tissues are perfused in vitro for 10 days, during which their fusion and longitudinal maturation are assessed. SWIFT kidney tissues maintained proper expression of glomerular, proximal tubule, distal tubule, stromal, and vascular cell types and architectures. Additionally, a progressive increase in nephron gene expression is observed via Nanostring analysis, highlighting the ability of SWIFT kidney tissues to undergo further maturation in vitro under flow. To explore their host integration and immune response, kidney tissue discs are fabricated by depositing the same OBB-ECM solution used for SWIFT into cylindrical molds. The kidney discs are cultured in vitro for 7 days to promote fusion, then implanted into NSG mice reconstituted with human allogeneic immune cells. Allogeneic immune cells infiltrated the discs and attacked nephron cell types within the transplanted tissues. We find that in vivo immune response towards the transplanted tissue discs exhibit a gene signature akin to clinical acute cellular rejection. Collectively, this work provides a foundation for the biofabrication and development of kidney tissues constructed from OBBs, insight into the immunological challenge of implanting OBB-based tissues, and a platform for future immunosuppressant drug development.In summary, a scalable approach for creating kidney organoids, perfusable organoid-derived proximal tubules, and bulk kidney tissues derived from human induced pluripotent stem cells has been established. The utility of each of these moieties (organoids, tubules, and tissues) have been validated through a combination of in vitro and in vivo studies. This PhD research provides a foundation for generating patient-specific kidney tissues for drug testing and therapeutic applications.
일반주제명  
Bioengineering
일반주제명  
Biomedical engineering
일반주제명  
Biomechanics
키워드  
Human kidneys
키워드  
Tubular segments
키워드  
Stirred bioreactors
키워드  
Embryoid body
키워드  
Biomanufacturing
기타저자  
Harvard University Engineering and Applied Sciences - Engineering Sciences
기본자료저록  
Dissertations Abstracts International. 86-12B.
전자적 위치 및 접속  
로그인 후 원문을 볼 수 있습니다.

MARC

 008260126s2025        us                              c    eng  d
■001000017357726
■00520260202103552
■006m          o    d                
■007cr#unu||||||||
■020    ▼a9798280715462
■035    ▼a(MiAaPQ)AAI32041869
■040    ▼aMiAaPQ▼cMiAaPQ
■0820  ▼a610
■1001  ▼aAceves,  Jeffrey  Ooi.▼0(orcid)0009-0004-0757-9243
■24510▼aBiomanufacturing  of  Kidney  Organoids,  Perfusable  Proximal  Tubules,  and  Kidney  Tissues
■260    ▼a[Sl]▼bHarvard  University▼c2025
■260  1▼aAnn  Arbor▼bProQuest  Dissertations  &  Theses▼c2025
■300    ▼a145  p
■500    ▼aSource:  Dissertations  Abstracts  International,  Volume:  86-12,  Section:  B.
■500    ▼aAdvisor:  Lewis,  Jennifer  A.
■5021  ▼aThesis  (Ph.D.)--Harvard  University,  2025.
■520    ▼aHuman  kidneys  are  vital  organs  that  filter  blood,  regulate  electrolyte  homeostasis,  and  produce  urine.  These  complex  processes  are  carried  out  by  nephron  subunits  composed  of  glomeruli  and  tubular  segments  that  are  responsible  for  filtration  and  reabsorption,  respectively.  While  considerable  efforts  have  focused  on  the  fabrication  of  in  vitro  renal  models  that  recapitulate  nephron  structure  and  function  for  studying  nephrotoxicity  and  renal  development,  progress  remains  limited.  Kidney  organoids  derived  from  human  induced  pluripotent  stem  cells  (hiPSCs)  are  three  dimensional  (3D),  multicellular  structures  that  contain  many  of  the  cell  types  and  architectures  present  in  human  kidneys.  There  is  a  growing  interest  in  using  kidney  organoids  as  a  platform  for  improved  drug  screening  and  as  organ  building  blocks  (OBBs)  for  the  biomanufacturing  of  functional  kidney  tissues  for  modeling  tissue  development,  and  ultimately,  renal  replacement.The  overarching  goal  of  this  Ph.D.  thesis  is  to  generate  kidney  organoids  and  explore  their  use  as  building  blocks  for  biofabricating  perfusable  proximal  tubules,  and  bulk  kidney  tissues.  Specifically,  this  research  focuses  on  the  scalable  3D  differentiation  of  kidney  organoids  in  stirred  bioreactors  (STRs),  the  development  of  organoid-derived  perfusable  proximal  tubules-on-chip,  and  the  biofabrication  of  3D  kidney  tissues  for  in  vitro  and  in  vivo  assessment.  We  first  investigated  the  effect  of  hiPSC  seeding  density  and  stir  rate  on  embryoid  body  (EB)  formation  and  differentiation  efficiency.  Their  initial  differentiation  efficiency  was  roughly  70%,  which  motivated  the  development  of  an  optical-based  screening  method  to  rapidly  predict  differentiation  success.  Next,  the  concentration  and  timing  of  differentiation  reagents  along  with  improved  media  preparation  methods  were  implemented  to  further  enhance  the  differentiation  efficiency  of nephron-rich  kidney  organoids  to  roughly  95%.  The  STR-generated  kidney  organoids  exhibited  glomerular,  proximal  tubule,  distal  tubule,  stromal  and  vascular  cell  types  and  architectures.  Compared  to  kidney  organoids  differentiated  in  static  conditions,  STR-generated  kidney  organoids  demonstrated  increased  expression  of  tubular,  ciliary,  and  vascular  cell  types.  Most  importantly,  kidney  organoid  differentiation  in  stirred  bioreactors  greatly  increased  the  organoid  volume  produced  in  a  given  time  period  relative  to  2D  (static)  differentiation  methods.Next,  we  developed  an  organoid-derived  proximal  tubule  epithelial  cell  (OPTEC)-on-chip  model  that  exhibits  improved  drug  uptake  compared  to  those  based  on  tert1-immortalized  proximal  tubule  (PTEC-TERT)  cells.  First,  lotus  tetragonolobus  lectin  (LTL+)  proximal  tubule  cells  are  isolated  from  mature  kidney  organoids,  that  were  dissociated  into  individual  cells,  using  magnetic  activated  cell  sorting  (MACS)  and  expanded  in  vitro.  These  OPTECs  are  then  seeded  into  cylindrical  channels  embedded  within  an  optimized  extracellular  matrix  (ECM)  composed  of  gelatin-fibrin,  where  they  form  a  confluent  monolayer.  A  second  bare  channel  is  introduced  adjacent  to  this  3D  tubule  within  reusable  multiplexed  chips  to  mimic  basolateral  drug  uptake.  Our  3D  OPTEC-on-chip  model  exhibits  significant  upregulation  and  improved  polarization  of  organic  cation  2  (OCT2)  and  organic  anion  1/3  (OAT1/3)  transporters,  which  resulted  in  higher  drug  uptake  compared  to  PTEC-TERT-on-chip  controls.  Consequently,  OPTEC-on-chip  models  also  exhibited  a  higher  normalized  lactate  dehydrogenase  (LDH)  release  compared  to  those  controls  when  exposed  to  known  nephrotoxins,  cisplatin  and  aristolochic  acid.  Importantly,  LDH  release  could  be  diminished  by  adding  known  OCT2  and  OAT1/3  inhibitors.  This  integrated  multifluidic  OPTEC  platform  paves  the  way  for  personalized  kidney-on-chip  models  for  drug  screening  and  disease  modeling.Finally,  we  investigated  the  biofabrication  of  3D  kidney  tissues  from  OBBs  with  the  goal  of  modeling  in  vitro  tissue  development  and  assessing  their  host  integration  in  vivo.  Kidney  organoids  differentiated  from  hiPSCs  in  STRs  were  mixed  in  a  fibrinogen  solution  and  compacted  to  form  a  cellularly  dense  tissue  matrix.  Sacrificial  writing  into  functional  tissue  (SWIFT)  is  then used  to  print  sacrificial  ink  channels  into  the  OBB-ECM  matrix.  The  SWIFT  kidney  tissues  are  perfused  in  vitro  for  10  days,  during  which  their  fusion  and  longitudinal  maturation  are  assessed.  SWIFT  kidney  tissues  maintained  proper  expression  of  glomerular,  proximal  tubule,  distal  tubule,  stromal,  and  vascular  cell  types  and  architectures.  Additionally,  a  progressive  increase  in  nephron  gene  expression  is  observed  via  Nanostring  analysis,  highlighting  the  ability  of  SWIFT  kidney  tissues  to  undergo  further  maturation  in  vitro  under  flow.  To  explore  their  host  integration  and  immune  response,  kidney  tissue  discs  are  fabricated  by  depositing  the  same  OBB-ECM  solution  used  for  SWIFT  into  cylindrical  molds.  The  kidney  discs  are  cultured  in  vitro  for  7  days  to  promote  fusion,  then  implanted  into  NSG  mice  reconstituted  with  human  allogeneic  immune  cells.  Allogeneic  immune  cells  infiltrated  the  discs  and  attacked  nephron  cell  types  within  the  transplanted  tissues.  We  find  that  in  vivo  immune  response  towards  the  transplanted  tissue  discs  exhibit  a  gene  signature  akin  to  clinical  acute  cellular  rejection.  Collectively,  this  work  provides  a  foundation  for  the  biofabrication  and  development  of  kidney  tissues  constructed  from  OBBs,  insight  into  the  immunological  challenge  of  implanting  OBB-based  tissues,  and  a  platform  for  future  immunosuppressant  drug  development.In  summary,  a  scalable  approach  for  creating  kidney  organoids,  perfusable  organoid-derived  proximal  tubules,  and  bulk  kidney  tissues  derived  from  human  induced  pluripotent  stem  cells  has  been  established.  The  utility  of  each  of  these  moieties  (organoids,  tubules,  and  tissues)  have  been  validated  through  a  combination  of  in  vitro  and  in  vivo  studies.  This  PhD  research  provides  a  foundation  for  generating  patient-specific  kidney  tissues  for  drug  testing  and  therapeutic  applications.
■590    ▼aSchool  code:  0084.
■650  4▼aBioengineering
■650  4▼aBiomedical  engineering
■650  4▼aBiomechanics
■653    ▼aHuman  kidneys
■653    ▼aTubular  segments
■653    ▼aStirred  bioreactors
■653    ▼aEmbryoid  body
■653    ▼aBiomanufacturing
■690    ▼a0202
■690    ▼a0541
■690    ▼a0648
■71020▼aHarvard  University▼bEngineering  and  Applied  Sciences  -  Engineering  Sciences.
■7730  ▼tDissertations  Abstracts  International▼g86-12B.
■790    ▼a0084
■791    ▼aPh.D.
■792    ▼a2025
■793    ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17357726▼nKERIS▼z이  자료의  원문은  한국교육학술정보원에서  제공합니다.

미리보기

내보내기

chatGPT토론

Ai 추천 관련 도서


    신착도서 더보기
    최근 3년간 통계입니다.

    소장정보

    • 예약
    • 소재불명신고
    • 나의폴더
    • 우선정리요청
    • 비도서대출신청
    • 야간 도서대출신청
    소장자료
    등록번호 청구기호 소장처 대출가능여부 대출정보
    TF18955 전자도서 대출가능 마이폴더 부재도서신고 비도서대출신청 야간 도서대출신청

    * 대출중인 자료에 한하여 예약이 가능합니다. 예약을 원하시면 예약버튼을 클릭하십시오.

    해당 도서를 다른 이용자가 함께 대출한 도서

    관련 인기도서

    로그인 후 이용 가능합니다.